Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating retinal vessel leakage in cerebral small vessel disease

Official title: Retinal Vessel Leakage in Cerebral Small Vessel Disease: a Sub-study of the Mild Stroke Study 3

Run by University of Edinburgh · NCT06416371 · Data updated 2026-11-12

This study is trying to see if leaking blood vessels in the eyes can help us understand how serious cerebral small vessel disease is in people who have had mild strokes.

More Vascular Dementia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Edinburgh
Academic / other
Locations1 site (Edinburgh)
StatusRecruiting
StartedJanuary 13, 2025
Main results expectedFebruary 15, 2029
Study endsFebruary 15, 2029
Registry record updatedMarch 4, 2026
Trial IDNCT06416371 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who are part of the Mild Stroke Study 3 cohort and have had a contrast-enhanced MRI within the last 12 months.

Probably not a fit

Patients with conditions known to cause retinal leakage or severe dementia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the occurrence of leakage from retinal vessels in patients with cerebral small vessel disease (SVD). Using fluorescein angiography, participants will be assessed for retinal vessel leakage, which may correlate with the severity of their SVD. The study will recruit individuals from the Mild Stroke Study 3 cohort who have previously undergone brain scans and other evaluations. The findings could provide insights into the pathogenesis of SVD and offer a cost-effective alternative to MRI for monitoring disease progression.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and monitoring of cerebral small vessel disease through retinal imaging.

How similar studies have gone: While the approach of using retinal imaging in this context is innovative, similar studies have shown promise in linking retinal health to cerebral vascular conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Membership in the Mild Stroke Study 3 cohort
* Contrast enhanced MRI within 12 months
* Clear optical media in both eyes, as assessed by study investigator
* Best corrected visual acuity (near vision) ≥N36

Exclusion Criteria:

* Any condition known to cause retinal leakage (i.e., worse than background diabetic retinopathy, retinal vein occlusion, active uveitis, wet age-related macular degeneration, malignant hypertension)
* Previous treatment for retinal leakage (retinal laser, intravitreal anti-VEGF)
* Recent eye surgery
* Shallow anterior chambers as assessed by torch test
* Pregnancy, renal failure
* Severe dementia
* Known allergy to fluorescein
* History of allergy such as food or drug induced urticaria or history of bronchial asthma
* Any other severe or acute medical or psychiatric conditions
* Inability to give informed consent

Where it's running

  • NHS Lothian
    Edinburgh, United Kingdom
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.